Debanjan Bhattacharya
Overview
Explore the profile of Debanjan Bhattacharya including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
182
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Moriarty C, Gupta N, Bhattacharya D
Cell Biol Int
. 2025 Feb;
PMID: 40014265
Glioblastoma is a highly malignant and invasive type of primary brain tumor that originates from astrocytes. Glutamate, a neurotransmitter in the brain plays a crucial role in excitotoxic cell death....
2.
Bhattacharya D, Barrile R, Toukam D, Gawali V, Kallay L, Ahmed T, et al.
Cancers (Basel)
. 2024 Sep;
16(18.
PMID: 39335139
In non-small cell lung cancer (NSCLC) treatment, radiotherapy responses are not durable and toxicity limits therapy. We find that AM-101, a synthetic benzodiazepine activator of GABA(A) receptor, impairs the viability...
3.
Bhattacharya D, Barille R, Toukam D, Gawali V, Kallay L, Ahmed T, et al.
bioRxiv
. 2023 Dec;
PMID: 38076805
Highlights: Activating GABA(A) receptors intrinsic to lung primary and metastatic brain cancer cells triggers a cytotoxic response. GABA(A) receptor activation works as well as chemotherapeutic docetaxel in impairing lung cancer...
4.
Kallay L, Gawali V, Toukam D, Bhattacharya D, Jenkins A, Sengupta S, et al.
J Vis Exp
. 2023 Jul;
(196).
PMID: 37395566
Ion channels are critical for cell development and maintaining cell homeostasis. The perturbation of ion channel function contributes to the development of a broad range of disorders or channelopathies. Cancer...
5.
Kar A, Jain D, Kumar S, Rajput K, Pal S, Rana K, et al.
Sci Adv
. 2023 Jun;
9(26):eadf2746.
PMID: 37390205
Treatment of triple-negative breast cancer (TNBC) is challenging because of its "COLD" tumor immunosuppressive microenvironment (TIME). Here, we present a hydrogel-mediated localized delivery of a combination of docetaxel (DTX) and...
6.
Shiu F, Wong J, Bhattacharya D, Kuranaga Y, Parag R, Alsharif H, et al.
Basic Clin Pharmacol Toxicol
. 2023 Jun;
133(4):353-363.
PMID: 37337931
Brain-specific angiogenesis inhibitor 3 (ADGRB3/BAI3) belongs to the family of adhesion G protein-coupled receptors. It is most highly expressed in the brain where it plays a role in synaptogenesis and...
7.
Carter J, Li Z, Chen H, Greiner M, Bush C, Bhattacharya D, et al.
Addict Sci Clin Pract
. 2022 Nov;
17(1):60.
PMID: 36335381
Background: Medication for opioid use disorder (MOUD) reduces mortality, but few patients access MOUD. At a Federally Qualified Health Center (FQHC), we implemented a low barrier model of MOUD, including...
8.
Lechpammer M, Rao R, Shah S, Mirheydari M, Bhattacharya D, Koehler A, et al.
Cancers (Basel)
. 2022 Apr;
14(7).
PMID: 35406398
Glioblastoma, or glioblastoma multiforme (GBM, WHO Grade IV), is a highly aggressive adult glioma. Despite extensive efforts to improve treatment, the current standard-of-care (SOC) regimen, which consists of maximal resection,...
9.
Rao R, Shah S, Bhattacharya D, Toukam D, Caceres R, Pomeranz Krummel D, et al.
Front Physiol
. 2022 Mar;
13:839437.
PMID: 35350689
Ligand-gated ion channels are an ionotropic receptor subtype characterized by the binding of an extracellular ligand, followed by the transient passage of ions through a transmembrane pore. Ligand-gated ion channels...
10.
Bhattacharya D, Krummel D, Sengupta S
Transl Cancer Res
. 2022 Feb;
9(3):1322-1325.
PMID: 35117480
No abstract available.